Evotec SE (EVOTF) — Earnings Call Analysis & IR Page

Evotec SE is a Healthcare company operating in Drug Manufacturers - Specialty & Generic with a $1.19B market cap.

Most recent earnings call: Q1 FY26 on May 6, 2026.

21 earnings calls indexed on Spoken Alpha.

Behavioral analysis

Management language signature

Disclosures

Investor Relations

IR URL not yet extracted for EVOTF.

Transcripts

Recent earnings calls

Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.

All 21 calls

History

Earnings history

Reported quarters with consensus, surprise, and 1-day reaction context.

No earnings history available.

Peers

Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.

API

For developers and AI agents

The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for EVOTF.

$ curl https://api.spokenalpha.com/v1/companies/EVOTF

Get an API key API docs

FAQ

Frequently asked about EVOTF

Where can I find Evotec SE's (EVOTF) earnings call transcripts?

Spoken Alpha indexes EVOTF's earnings call transcripts at https://spokenalpha.com/companies/EVOTF. Each call links to attributed speakers and parsed analyst Q&A.

When was Evotec SE's most recent earnings call?

Evotec SE (EVOTF) held its most recent earnings call on 2026-05-06, covering fiscal Q1 2026.

What sector is EVOTF in?

Evotec SE (EVOTF) operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

Overview